Effects of a nitroxybutylester derivative of aspirin (NCX 4215) on platelet aggregation and prostanoid synthesis were compared to the effects of aspirin. NCX 4215 was approximately seven times more potent than aspirin as an inhibitor of thrombin-induced human platelet aggregation in vitro, but did not inhibit platelet thromboxane synthesis or gastric prostaglandin synthesis. NCX 4215 released nitric oxide when incubated in the presence of platelets and increased platelet levels of cGMP within 10 min of exposure, while aspirin did not. The anti-aggregatory effects of NCX 4215 in vitro were significantly attenuated by 10 microM hemoglobin. In ex vivo studies of ADP- or collagen- or thrombin-induced rat platelet aggregation, aspirin and NCX 4215 had comparable inhibitory effects 3 h after administration. Aspirin (10-120 mg/kg) caused extensive hemorrhagic erosion formation in the stomach of the rat within 3 h of oral administration, while NCX 4215 did not produce significant damage at doses of up to 300 mg/kg, nor when given daily for two weeks at 166 mg/kg. NCX 4215 did not alter systemic arterial blood pressure when administered intravenously to the rat. These studies demonstrate that NCX 4215 has comparable or enhanced anti-thrombotic activity to that of aspirin, but does not cause gastric damage or alter systemic blood pressure. The anti-thrombotic actions of NCX 4215 are, at least in part, due to generation of nitric oxide.
J L Wallace, W McKnight, P Del Soldato, A R Baydoun, G Cirino
Title and authors | Publication | Year |
---|---|---|
Nitric oxide: new evidence for novel therapeutic indications
SJ Wimalawansa |
Expert Opinion on Pharmacotherapy | 2008 |
Nitric oxide and cardiovascular effects: new insights in the role of nitric oxide for the management of osteoarthritis
IS Mackenzie, D Rutherford, TM MacDonald |
Arthritis Research & Therapy | 2008 |
Risk Factors for Gastrointestinal Complications in Aspirin Users: Review of Clinical and Experimental Data
FW Leung |
Digestive Diseases and Sciences | 2008 |
NO donor hybrid compounds as multifunctional therapeutic agents
L Fang, J Lehmann |
Expert Opinion on Therapeutic Patents | 2008 |
Gastroprotective Effect of Nicorandil in Indomethacin and Alcohol-Induced Acute Ulcers
MA El-Moselhy, NM Abdel-Hamid, SR Abdel-Raheim |
Applied Biochemistry and Biotechnology | 2008 |
A novel hybrid aspirin-NO-releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages
CM Turnbull, P Marcarino, TA Sheldrake, L Lazzarato, C Cena, R Fruttero, A Gasco, S Fox, IL Megson, AG Rossi |
Journal of Inflammation | 2008 |